Gefitinib affords QOL benefits for NSCLC patients in free access programme
KeywordsLung Cancer Cell Lung Cancer Improve Quality Medical Director Outcome News
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
© Adis International Ltd 2003